Fabtech Cleanrooms Limited reports October 2026 order bookings and updates
Fabtech Technologies Cleanrooms · Industrial Manufacturing
Key highlights
- Secured consolidated orders worth ₹27.75 crore in October 2026 across Pharma, Renewable Energy, Data Centres, and Others
- Consolidated order book as of 31 October 2026 is ₹468.50 crore including Renewable Energy (₹188.52 crore) and Pharma (₹224.90 crore)
- Orders under active consideration total ₹552.83 crore with major opportunities in Pharma (₹256.28 crore) and Renewable Energy (₹205.69 crore)
Original filing
Order Booking And Updates
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Engineering Services
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other order win filings this fortnight
- Order winArmee InfotechArMee Infotech signs MoU with MSEDCL for 135 MW solar power project
- Order winAdvait Energy TransitionsAdvait Energy Transitions receives ₹130.48 crore order from GETCO for reconductoring
- Order winAshoka BuildconAshoka Buildcon declared Lowest Bidder for NHAI expressway project worth ₹1465 Cr
- Order winAmeenji RubberAmeenji Rubber Limited receives ₹21.44 crore purchase order from Eastern Railway
- Order winDhabriya PolywoodDhabriya Polywood Ltd receives ₹12.20 crore work order from Godrej Group
- Order winPositron EnergyPositron Energy Limited receives order for supply of RLNG worth ₹40 Crores
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Manufacturing
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
